Anti-DC-SIGN/CD209 Antibody (INSERM patent anti-DC-SIGN)
Catalog No.
F1148
Anti-DC-SIGN/CD209 Antibody (INSERM patent anti-DC-SIGN)
Featured Products
Anti-DC-SIGN / CD209 is a humanized monoclonal antibody specifically targeting DC-SIGN. It can inhibit infection caused by human cytomegalovirus (CMV) in immunocompromised patients (i.e. organ transplant recipients or AIDS patients). Molecular weight: 146.62 KD.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
INSERM patent anti-DC-SIGN
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NNX6
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
DC-SIGN / CD209
Please avoid freeze-thaw cycles.